Brain and Central Nervous System Tumors — Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
Citation(s)
Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes